Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly/Icos Cialis Clears FDA; 36 Hour Efficacy Claim Applies To Starting Dose

Executive Summary

Lilly/Icos will be able to make a 36-hour efficacy claim for the 10 mg starting dose of the erectile dysfunction treatment Cialis (tadalafil)

You may also be interested in...



Levitra Detailing Message Is “Rapid And Reliable”; Onset Of Action Studied

Bayer and GlaxoSmithKline are positioning Levitra as "rapid" and "reliable" in communications with doctors

Levitra Detailing Message Is “Rapid And Reliable”; Onset Of Action Studied

Bayer and GlaxoSmithKline are positioning Levitra as "rapid" and "reliable" in communications with doctors

Gilead Leads Biotech Rebound In 2003: Product Stories Play Well

Gilead Sciences is leading a new wave of biotech stocks attempting to break out of the start-up phase to become full-fledged biopharma companies

Related Content

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel